glp-1 colorectal cancer death risk study november 2025 ASCO GI 2026: receptor agonists (GLP-1s) may help reduce the of developing Long-term cancer risk in users

He H, Zhao Z, Xiao C, Li L, Liu YE, Fu J, et al

Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency

Used alone, it provides a clean pre-workout experience elevated body temperature, increased sweating, metabolic activation without CNS stimulation.

Competing interests LR has received a grant from Novo Nordisk Foundation (grant number: NNF24OC0091713) for an investigator sponsored randomized controlled trial for which Mylife Diabetes Care AG donates insulin pumps and accessories and Abbott donates continued glucose monitoring devices, and participated in the European Association for the Study of Diabetes annual meeting 2023 as an invite by Novo Nordisk

Not intended to diagnose or treat disease

D., & Carr, T